AAAAAA
Results: 1-25/57
Authors:
WISEMAN LR
BROGDEN RN
Citation: Lr. Wiseman et Rn. Brogden, PROPIONYL-L-CARNITINE, Drugs & aging, 12(3), 1998, pp. 243-248
Authors:
BROGDEN RN
WISEMAN LR
Citation: Rn. Brogden et Lr. Wiseman, TOPOTECAN - A REVIEW OF ITS POTENTIAL IN ADVANCED OVARIAN-CANCER, Drugs, 56(4), 1998, pp. 709-723
Authors:
BROGDEN RN
GOA KL
COUKELL AJ
Citation: Rn. Brogden et al., AMPHOTERICIN-B COLLOIDAL DISPERSION - A REVIEW OF ITS USE AGAINST SYSTEMIC FUNGAL-INFECTIONS AND VISCERAL LEISHMANIASIS, Drugs, 56(3), 1998, pp. 365-383
Authors:
BROGDEN RN
WISEMAN LR
Citation: Rn. Brogden et Lr. Wiseman, MOEXIPRIL - A REVIEW OF ITS USE IN THE MANAGEMENT OF ESSENTIAL-HYPERTENSION, Drugs, 55(6), 1998, pp. 845-860
Authors:
FOSTER RH
BROGDEN RN
BENFIELD P
Citation: Rh. Foster et al., TAZAROTENE, Drugs, 55(5), 1998, pp. 705-711
Authors:
BARTOW RA
BROGDEN RN
Citation: Ra. Bartow et Rn. Brogden, FORMOTEROL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF ASTHMA. (VOL 55, PG 303, 1997), Drugs, 55(4), 1998, pp. 517-517
Authors:
BROGDEN RN
MARKHAM A
Citation: Rn. Brogden et A. Markham, MIBEFRADIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HYPERTENSION ANDANGINA PECTORIS. (VOL 54, PG 774, 1997), Drugs, 55(4), 1998, pp. 517-517
Authors:
COUKELL AJ
BROGDEN RN
Citation: Aj. Coukell et Rn. Brogden, LIPOSOMAL AMPHOTERICIN-B - THERAPEUTIC USE IN THE MANAGEMENT OF FUNGAL-INFECTIONS AND VISCERAL LEISHMANIASIS, Drugs, 55(4), 1998, pp. 585-612
Authors:
BARTOW RA
BROGDEN RN
Citation: Ra. Bartow et Rn. Brogden, FORMOTEROL - AN UPDATE OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF ASTHMA, Drugs, 55(2), 1998, pp. 303-322
Authors:
ADKINS JC
BROGDEN RN
Citation: Jc. Adkins et Rn. Brogden, ZAFIRLUKAST - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE MANAGEMENT OF ASTHMA, Drugs, 55(1), 1998, pp. 121-144
Authors:
BROGDEN RN
WAGSTAFF AJ
Citation: Rn. Brogden et Aj. Wagstaff, RIMEXOLONE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN THE MANAGEMENT OF OCULAR INFLAMMATION, Biodrugs, 8(1), 1997, pp. 68-79
Authors:
HARIA M
BROGDEN RN
Citation: M. Haria et Rn. Brogden, IOHEXOL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND USE AS A CONTRAST-MEDIUM IN MYELOGRAPHY AND NEUROANGIOGRAPHY, CNS DRUGS, 7(3), 1997, pp. 229-255
Authors:
FULTON B
BROGDEN RN
Citation: B. Fulton et Rn. Brogden, BUSPIRONE - AN UPDATED REVIEW OF ITS CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS, CNS DRUGS, 7(1), 1997, pp. 68-88
Authors:
BROGDEN RN
MARKHAM A
Citation: Rn. Brogden et A. Markham, MIBEFRADIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HYPERTENSION ANDANGINA-PECTORIS, Drugs, 54(5), 1997, pp. 774-793
Authors:
BROGDEN RN
MARKHAM A
Citation: Rn. Brogden et A. Markham, FENOLDOPAM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND INTRAVENOUS CLINICAL POTENTIAL IN THE MANAGEMENT OF HYPERTENSIVE URGENCIES AND EMERGENCIES, Drugs, 54(4), 1997, pp. 634-650
Authors:
LANGTRY HD
BROGDEN RN
Citation: Hd. Langtry et Rn. Brogden, CLARITHROMYCIN - A REVIEW OF ITS EFFICACY IN THE TREATMENT OF RESPIRATORY-TRACT INFECTIONS IN IMMUNOCOMPETENT PATIENTS, Drugs, 53(6), 1997, pp. 973-1004
Authors:
BROGDEN RN
GOA KL
Citation: Rn. Brogden et Kl. Goa, ADAPALENE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN THE MANAGEMENT OF MILD-TO-MODERATE ACNE (VOL 53, PG 511, 1997), Drugs, 53(5), 1997, pp. 827-827
Authors:
BROGDEN RN
SPENCER CM
Citation: Rn. Brogden et Cm. Spencer, CEFOTAXIME - A REAPPRAISAL OF ITS ANTIBACTERIAL ACTIVITY AND PHARMACOKINETIC PROPERTIES, AND A REVIEW OF ITS THERAPEUTIC EFFICACY WHEN ADMINISTERED TWICE-DAILY FOR THE TREATMENT OF MILD-TO-MODERATE INFECTIONS, Drugs, 53(3), 1997, pp. 483-510
Authors:
BROGDEN RN
GOA KL
Citation: Rn. Brogden et Kl. Goa, ADAPALENE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN THE MANAGEMENT OF MILD-TO-MODERATE ACNE, Drugs, 53(3), 1997, pp. 511-519
Authors:
GILLIS JC
BROGDEN RN
Citation: Jc. Gillis et Rn. Brogden, KETOROLAC - A REAPPRAISAL OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PAIN MANAGEMENT, Drugs, 53(1), 1997, pp. 139-188
Authors:
PLOSKER GL
BROGDEN RN
Citation: Gl. Plosker et Rn. Brogden, SERENOA REPENS (PERMIXON(R)) - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN BENIGN PROSTATIC HYPERPLASIA, Drugs & aging, 9(5), 1996, pp. 379-395
Authors:
BARRADELL LB
BROGDEN RN
Citation: Lb. Barradell et Rn. Brogden, ORAL NAFTIDROFURYL - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USEIN THE MANAGEMENT OF PERIPHERAL OCCLUSIVE ARTERIAL-DISEASE, Drugs & aging, 8(4), 1996, pp. 299-322
Authors:
BROGDEN RN
WISEMAN LR
Citation: Rn. Brogden et Lr. Wiseman, ACECLOFENAC - A REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF RHEUMATIC DISORDERS AND IN PAIN MANAGEMENT, Drugs, 52(1), 1996, pp. 113-124
Authors:
PERRY CM
BROGDEN RN
Citation: Cm. Perry et Rn. Brogden, CEFUROXIME AXETIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY, Drugs, 52(1), 1996, pp. 125-158
Authors:
BROGDEN RN
BENFIELD P
Citation: Rn. Brogden et P. Benfield, VERAPAMIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CORONARY-ARTERY DISEASE, Drugs, 51(5), 1996, pp. 792-819